Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine on Emotional Processing in Healthy Volunteers
NCT03961464Completed
- Sponsor
- University of Oxford
- Start
- Aug 2018
- Primary completion
- Dec 2018
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in major depressive disorder (MDD) comparing d-cycloserine with Placebo (2 arms). Primary endpoints: Performance in a facial expression recognition task at 3 hours, Performance in an emotional recall task at 3 hours and 1 more. Started Aug 2018; status: completed.
02
Drugs
d-cycloserine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03961464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03961464.